Abstract
BackgroundFor most DMARD-IR patients (pts) with severe active RA, therapy with a biologic and methotrexate (MTX) is effective. However, nearly 1/3 discontinue or are non-compliant with MTX because of toxicity...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have